We also found a high proportion of VUSs in the MMR genes (47%) among the VUSs that suggest pathogenicity at some level, together with changes in other genes, e.g., POLE, APC, and BMPR1A. These variants could be better classified if further testing was available such as tumor sequencing. The gene discussed is MRC1; the disease is neoplasm.